[1] Scherer P E, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45):26746-26749. [2] Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism[J]. J Physiol Pharmacol, 2006, 57 Suppl 6:103-113.[3] Adams V, Heiker JT, H?llriegel R, et al.Adiponectin promotes the migration of circulating angiogenic cells through p38-mediated induction of the CXCR4 receptor[J]. Int J Cardiol, 2013,167(5):2039-2046.[4] Yin T, Li L. The stem cell niches in bone[J]. J Clin Invest, 2006, 116(5):1195-1201.[5] Wan M, Li C, Zhen G et al. Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling[J]. Stem Cells, 2012, 30(11):2498-2511.[6] Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche[J]. Nature, 2010, 466(7308):829-834. [7] Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in [J]. J Exp Med, 2011,208 (3):421-428.[8] Hoshiba T, Kawazoe N, Chen G. The balance of osteogenic and adipogenic differentiation in human mesenchymal stem cells by matrices that mimic stepwise tissue development [J]. Biomaterials, 2012 ,33(7):2025-2031.[9] Hammoudi TM, Rivet CA, Kemp ML, et al. Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes [J]. Tissue Eng Part A, 2012, 18(15-16):1686-1697.[10] Lin Z, Tian H, Lam KS, et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice [J]. Cell Metab, 2013, 17(5):779-789.[11] Jenke A, Wilk S, Poller W, et al. Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury [J]. Cardiovasc Res, 2013, 99(3):422-431.[12] van Stijn CM, Kim J, Barish GD, et al. Adiponectin expression protects against Angiotensin II-mediated inflammation and accelerated atherosclerosis[J]. PLoS One. 2014 ,22;9(1):e86404.[13] Luo E, Hu J, Bao C, et al. Sustained release of adiponectin improves ostegenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits [J]. Acta Biomater, 2012,8(2):734-743.[14] Lee HW, Kim SY, Kim AY, et al. Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells [J]. Stem Cells, 2009, 27(9): 2254-2262.[15] Luo XH, Guo LJ, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway [J]. J Bone Miner Res, 2006, 21(10): 1648-1656.[16] Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking[J]. Stem Cells Int, 2013, 2013:130763. [17]Ratajczak M Z, Kim C H , Abdel-Latif A, et al. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients [J]. Leukemia, 2012, 26(1):63-72. [18] Theiss HD, VallasterM, Rischpler C , et al. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis [J]. Stem Cell Res. 2011, 7(3): 244-255.[19] Kitaori T, Ito H, Schwarz EM, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model [J]. Arthritis & Rheum, 2009, 60 (3):813-823. |